no key · no human

BiopharmaWatch API, RSS and sitemap

Every article BiopharmaWatch publishes, as JSON, through an open API with no key and no signup. 4,237 of their articles are indexed right now, refreshed hourly.

English#1,861 by volume

Four ways to pull biopharmawatch.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from biopharmawatch.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=www.biopharmawatch.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=www.biopharmawatch.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 39%crypto 13%business 11%society 11%

Call the API

A live request. Paste it into a terminal and BiopharmaWatch headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&size=5"
4,237
articles indexed
2,505
in the last 30 days
83
median per day
1
languages
14 min
median crawl lag
25.08 → 22.10
archive depth

Publishing volume

Articles per day over the last 57 days. The busiest hour is 12:00 UTC — that is when the newsroom pushes its main batch.

2026-08-25: 46 articles2026-08-26: 66 articles2026-08-27: 104 articles2026-08-28: 79 articles2026-08-29: 6 articles2026-08-30: 4 articles2026-08-31: 87 articles2026-09-01: 143 articles2026-09-02: 116 articles2026-09-03: 106 articles2026-09-04: 79 articles2026-09-06: 2 articles2026-09-07: 6 articles2026-09-08: 177 articles2026-09-09: 106 articles2026-09-10: 100 articles2026-09-11: 39 articles2026-09-13: 4 articles2026-09-14: 93 articles2026-09-15: 83 articles2026-09-16: 75 articles2026-09-17: 76 articles2026-09-18: 62 articles2026-09-19: 4 articles2026-09-20: 5 articles2026-09-21: 64 articles2026-09-22: 103 articles2026-09-23: 89 articles2026-09-24: 78 articles2026-09-25: 65 articles2026-09-26: 8 articles2026-09-27: 3 articles2026-09-28: 97 articles2026-09-29: 115 articles2026-09-30: 106 articles2026-10-01: 144 articles2026-10-02: 168 articles2026-10-03: 4 articles2026-10-04: 9 articles2026-10-05: 101 articles2026-10-06: 113 articles2026-10-07: 94 articles2026-10-08: 126 articles2026-10-09: 96 articles2026-10-10: 10 articles2026-10-11: 6 articles2026-10-12: 77 articles2026-10-13: 108 articles2026-10-14: 102 articles2026-10-15: 137 articles2026-10-16: 90 articles2026-10-17: 2 articles2026-10-18: 10 articles2026-10-19: 74 articles2026-10-20: 107 articles2026-10-21: 133 articles2026-10-22: 130 articles08-2509-0309-1409-2310-0210-1110-2010-22
bash
curl "https://freenewsapi.ai/v1/stats?host=www.biopharmawatch.com&top=10"

Publishing rhythm

When BiopharmaWatch actually publishes, by hour of day (UTC) and by day of week — measured from 4,237 timestamps, not from a schedule they advertise.

00: 570001: 90102: 250203: 70304: 110405: 360506: 410607: 400708: 560809: 310910: 2551011: 7681112: 1,1661213: 3901314: 631415: 681516: 681617: 401718: 521819: 391920: 8082021: 1002122: 782223: 2923
Mon: 599MonTue: 995TueWed: 887WedThu: 1,001ThuFri: 678FriSat: 34SatSun: 43Sun

Sections

Sections come from the publisher's own markup, present on 46% of their articles.

SectionArticles
health1,947

Languages

CodeLanguageArticlesShare
enEnglish4,237100.0%

Latest articles

The 18 most recent BiopharmaWatch articles in the index — the same rows the API returns, rendered for humans.

Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at AS
2026-10-22 22:40 UTC
Mineralys presented new lorundrostat data at ASN Kidney Week 2026, showing significant blood pressure reductions and a 52% decrease in albuminuria.
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
2026-10-22 22:27 UTC
Immuron's CEO Steven Lydeamore will present at the Emerging Growth Conference on October 28, 2026, discussing their innovative therapies.
Encompass Health Rehabilitation Hospital of Westover Hills now open in Texas
2026-10-22 20:30 UTC
Encompass Health opens a new rehabilitation hospital in San Antonio, Texas, offering specialized care for various conditions.
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
2026-10-22 20:30 UTC
CVRx will report its Q3 2026 financial results on November 5, 2026, and host a conference call.
Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
2026-10-22 20:30 UTC
Charles River collaborates with FDA and Labcorp to develop new tools for assessing drug abuse potential, enhancing safety evaluations.
Agenus to Provide Third Quarter 2026 Financial Report and Development Update
2026-10-22 20:30 UTC
Agenus will release its Q3 2026 financial results on November 5, detailing progress in cancer therapies.
Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse
2026-10-22 20:30 UTC
Labcorp collaborates with FDA and Charles River to enhance drug abuse potential evaluation methods, supporting safer drug development.
Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing
2026-10-22 20:20 UTC
Lucid Diagnostics begins Medicare reimbursement for EsoGuard, enhancing cancer prevention access and closes $15 million financing.
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results
2026-10-22 20:10 UTC
Artivion will release its Q3 2026 financial results on November 5, 2026. Join the teleconference at 4:30 p.m. ET for insights.
Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Neph
2026-10-22 20:05 UTC
Vor Bio's telitacicept shows significant kidney function preservation in IgA nephropathy, with a 5.1 mL/min/1.73 m²/year improvement over placebo.

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=www.biopharmawatch.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well BiopharmaWatch marks up its own pages — useful if you are deciding whether to parse them yourself.

0%
dates from JSON-LD
0%
articles with a byline
46%
articles with sections
—
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 14 min at the median, 2811 minutes at the 90th percentile.

Similar publishers

Comparable outlets in the same language. Those without a page here yet link straight to their slice of the API.

FAQ

Does BiopharmaWatch have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 4,237 of their articles and lets you filter by date, language and section.

How many articles does BiopharmaWatch publish per day?

83 on a median day, measured across 57 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.